[HTML][HTML] The comparative effect of nisin and thioridazine as potential anticancer agents on hepatocellular carcinoma
NES Ibrahim, H Morsy, M Abdelgwad - Reports of biochemistry & …, 2021 - ncbi.nlm.nih.gov
Background: Hepatocellular carcinoma is a major health problem worldwide especially in
Egypt. It accounts for the fifth common cancer and the second cause of death among …
Egypt. It accounts for the fifth common cancer and the second cause of death among …
[PDF][PDF] 核苷类抗病毒药物治疗乙肝肝硬化患者的疗效分析
王驭风， 夏澍， 钱卫 - 2013 - jcmp.yzu.edu.cn
核苷类抗病毒药物治疗乙肝肝硬化患者的疗效分析 Page 1 2013年第17卷第14期 实用临床医药
杂志 Journal of Ctinical Medicine in Practice ·43· 核苷类抗病毒药物治疗乙肝肝硬化患者的疗效 …
杂志 Journal of Ctinical Medicine in Practice ·43· 核苷类抗病毒药物治疗乙肝肝硬化患者的疗效 …
[HTML][HTML] Strong correlation of MTHFR gene polymorphisms with breast cancer and its prognostic clinical factors among Egyptian females
MH Omran, BE Fotouh, WG Shosha… - Asian Pacific Journal …, 2021 - ncbi.nlm.nih.gov
Results: The present data showed a strong significant association between the CT and TT of
MTHFR (C677T), and AC and CC of (A1289C) with the susceptibility of BC showing highly …
MTHFR (C677T), and AC and CC of (A1289C) with the susceptibility of BC showing highly …
Three gene signature for predicting the development of hepatocellular carcinoma in chronically infected hepatitis C virus patients
MK Ibrahim, H Salama, M Abd El Rahman… - Journal of Interferon & …, 2016 - liebertpub.com
Hepatitis C virus (HCV) is the leading cause of liver fibrosis and hepatocellular carcinoma
(HCC). At present, there is no predictive biomarker for the patients at high risk of developing …
(HCC). At present, there is no predictive biomarker for the patients at high risk of developing …
Interleukin-17A and Interleukin-17F Gene Polymorphisms in Egyptian Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
A El-Maksoud, E Mabrouk, NES Ibrahim… - Asian Pacific Journal …, 2025 - journal.waocp.org
Objective: Interleukin IL-17A and IL-17F are critical cytokines involved in inflammatory
processes. Genetic variations in IL-17A and IL-17F might be linked to chronic hepatitis C …
processes. Genetic variations in IL-17A and IL-17F might be linked to chronic hepatitis C …
Association study of TAP and HLA‐I gene combination with chronic hepatitis C virus infection in a Han population in China
Y Tao, X Han, N Liu, L Shi, L Shi… - International Journal of …, 2022 - Wiley Online Library
Host immune system genes play key roles in the progression of chronic hepatitis C virus
(HCV) infection. Transporters associated with antigen processing (TAP) play an important …
(HCV) infection. Transporters associated with antigen processing (TAP) play an important …
[HTML][HTML] A study of CC-chemokine receptor 5 (CCR5) polymorphism on the outcome of HCV therapy in Egyptian patients
MH Omran, M Khamis, N Nasr, AA Massoud… - Hepatitis …, 2013 - ncbi.nlm.nih.gov
Background: Chronic hepatitis C virus (HCV) infection is a globally serious public health
issue. Objectives: In this study, we investigated CC chemokine receptor 5 (CCR5-59029) …
issue. Objectives: In this study, we investigated CC chemokine receptor 5 (CCR5-59029) …
Insulin-like Growth Factor Initiates Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients through Induction of Long Non-coding Ribonucleic Acids AF085935 …
HCV is the most commonly occurring hepatic infection worldwide. Chronic HCV infection
usually complicated with cirrhosis and even HCC with significant morbidity and mortality …
usually complicated with cirrhosis and even HCC with significant morbidity and mortality …
[PDF][PDF] Low Molecular Mass Polypeptide 7 single nucleotide polymorphism is associated with the progression of liver fibrosis in patients infected with hepatitis C virus …
MK El Awady, MH Omran, MK Ibrahim, AM Moustafa… - Clin Lab, 2016 - researchgate.net
Background: The hepatitis C virus (HCV) is a leading cause of liver disease and the
consequent complications of cirrhosis. However, there is no precise biomarker to predict the …
consequent complications of cirrhosis. However, there is no precise biomarker to predict the …